Company / SG&A per Share
LIPELLA PHARMACEUTICALS INC. SG&A per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.65
FY2024
5-year range
$0.06 / $2.65
FY2022-FY2024
Trend
+605.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +605% YoY in FY2024, a notable deviation from the 2-year average annual change of +574%.
Based on SEC 10-K filings.
2.65 in FY2024.
Increased from $0.06 to $2.65 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, sg&a per share increased 605.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.65 | +605.2% |
| FY2023 | $0.38 | +541.9% |
| FY2022 | $0.06 | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 29, 2026